MAZE — Maze Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1842295 ·
Last close
$32.87
Market Cap
$1.80B
52W High
$53.65
52W Low
$21.95
ADV30
740,035
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -51,517,000 | -47,969,000 | 511,557,000 | 154,156,000 | 83,012,000 |
| Jun 2026 | 0 | — | -48,035,000 | -44,727,000 | 531,625,000 | 202,643,000 | 78,501,000 |
| Mar 2026 | 20,000,000 | — | -26,553,000 | -24,208,000 | 419,710,000 | 198,766,000 | 78,009,000 |
| Dec 2025 | 0 | — | -38,059,000 | -34,568,000 | 397,127,000 | 189,247,000 | 42,161,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-114,739,000
Investing CF
$-257,028,000
Financing CF
$209,149,000
CapEx
$-522,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.65
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-606,451,000
Inventory
—
Receivables
$20,000,000
ST Investments
$235,502,000
EBIT TTM
$-152,191,000
Pretax Income TTM
$-151,472,000
Interest Exp TTM
$2,772,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,000,000
EBITDA
$-162,444,992
Free Cash Flow
$-68,622,000
Enterprise Value
$1,547,264,256
Total Cash
$389,657,984
Total Debt
$59,643,000
Shares Out
54,683,345
Trailing EPS
$-2.62
Book Value
$7.59
ROE
-37.5%
ROA
-22.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -142,899,000 | -131,120,000 | 397,127,000 | 42,161,000 | 354,966,000 | -111,940,000 |
| Dec 2024 | 167,500,000 | 57,586,000 | 52,231,000 | 240,542,000 | 551,725,000 | -311,183,000 | 75,954,000 |
| Dec 2023 | 0 | -98,551,000 | -100,415,000 | 71,504,000 | 445,352,000 | -373,848,000 | -86,827,000 |
| Dec 2022 | 0 | -111,026,000 | -114,940,000 | 149,957,000 | 432,416,000 | -282,459,000 | -99,203,000 |
TTM Snapshot
Revenues TTM
$20,000,000
NetIncome TTM
$-133,590,000
OpCashFlow TTM
—
Assets (Latest)
$531,625,000
Forward EPS
$-3.30
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $31.20 · call volume: 19 · put volume: 1
Expected Move to 2027-01-15:
±$12.75
(40.87%) —
implied range
$18.45 –
$43.95
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, Inc. | $1.83B | $39.06 | — |
| REPL | Replimune Group, Inc. | $1.87B | $19.69 | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | $1.69B | $2.72 | — |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $1.93B | $7.50 | — |
| LYCA | Lycia Therapeutics, Inc. | $1.61B | $30.92 | — |
News headlines (Yahoo Finance, 1h cache)
Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
2026-11-09 21:05 · Yahoo
Wall Street Analysts Predict a 93.92% Upside in Maze Therapeutics, Inc. (MAZE): Here's What You Should Know
2026-11-04 13:55 · Yahoo
Maze Therapeutics to Participate in Upcoming Investor Conferences
2026-11-03 12:00 · Yahoo
What Makes Maze Therapeutics, Inc. (MAZE) a New Buy Stock
2026-10-19 15:00 · Yahoo
How Much Upside is Left in Maze Therapeutics, Inc. (MAZE)? Wall Street Analysts Think 123.39%
2026-10-19 12:55 · Yahoo
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
2026-10-13 14:31 · Yahoo
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
2026-10-06 20:05 · Yahoo
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
2026-09-29 00:37 · Yahoo
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?
2026-09-25 04:23 · Yahoo
Maze Therapeutics Shares Rise 2.9% After CIBC Initiates Coverage
2026-09-23 12:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.